ArticleOxidative medicine and cellular longevity2019

LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline.

Abhilasha Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.